[FWP] Morgan Stanley Free Writing Prospectus
Morgan Stanley Finance has announced Worst-of SPX and INDU Trigger PLUS securities due July 22, 2031, offering leveraged exposure to the worse performing of the S&P 500® Index and Dow Jones Industrial Average℠. Key features include:
- Leverage factor of at least 158% on positive underlier performance
- Principal protection against declines up to 20% from initial levels
- Downside threshold level at 80% of initial level for each underlier
- Estimated value of $961.80 per security
Notable risks include potential loss of principal, no interest payments, and exposure to worst-performing underlier only. The securities are subject to Morgan Stanley's credit risk and will not be listed on any exchange. The payment at maturity ranges from $0 (complete loss) if worst underlier declines 100% to $1,948 if worst underlier gains 60% (assuming 158% leverage). The offering demonstrates Morgan Stanley's continued innovation in structured products while highlighting the balance between enhanced returns and investment risks.
Morgan Stanley Finance ha annunciato i titoli Worst-of SPX and INDU Trigger PLUS con scadenza il 22 luglio 2031, che offrono un'esposizione con leva al peggior rendimento tra l'indice S&P 500® e il Dow Jones Industrial Average℠. Le caratteristiche principali includono:
- Fattore di leva di almeno il 158% sulle performance positive del sottostante
- Protezione del capitale contro cali fino al 20% dai livelli iniziali
- Livello soglia di ribasso al 80% del livello iniziale per ciascun sottostante
- Valore stimato di 961,80 dollari per titolo
I rischi principali comprendono la possibile perdita del capitale, l'assenza di pagamenti di interessi e l'esposizione esclusiva al sottostante con la performance peggiore. I titoli sono soggetti al rischio di credito di Morgan Stanley e non saranno quotati in alcun mercato. Il pagamento a scadenza varia da 0 dollari (perdita totale) se il peggior sottostante perde il 100%, fino a 1.948 dollari se il peggior sottostante guadagna il 60% (considerando la leva del 158%). L'offerta rappresenta l'innovazione continua di Morgan Stanley nei prodotti strutturati, evidenziando l'equilibrio tra rendimenti potenziati e rischi d'investimento.
Morgan Stanley Finance ha anunciado los valores Worst-of SPX and INDU Trigger PLUS con vencimiento el 22 de julio de 2031, que ofrecen exposición apalancada al peor desempeño entre el índice S&P 500® y el Dow Jones Industrial Average℠. Las características clave incluyen:
- Factor de apalancamiento de al menos 158% sobre el rendimiento positivo del subyacente
- Protección del capital contra caídas de hasta el 20% desde los niveles iniciales
- Nivel umbral a la baja del 80% del nivel inicial para cada subyacente
- Valor estimado de $961.80 por título
Los riesgos destacados incluyen la posible pérdida del capital, la ausencia de pagos de intereses y la exposición únicamente al subyacente con peor rendimiento. Los valores están sujetos al riesgo crediticio de Morgan Stanley y no estarán listados en ninguna bolsa. El pago al vencimiento varía desde $0 (pérdida total) si el peor subyacente cae un 100% hasta $1,948 si el peor subyacente gana un 60% (asumiendo un apalancamiento del 158%). La oferta demuestra la continua innovación de Morgan Stanley en productos estructurados, resaltando el equilibrio entre retornos mejorados y riesgos de inversión.
모건 스탠리 파이낸스는 2031년 7월 22일 만기인 Worst-of SPX and INDU Trigger PLUS 증권을 발표했습니다. 이 증권은 S&P 500® 지수와 다우 존스 산업평균지수℠ 중 성과가 더 나쁜 지수에 대해 레버리지 노출을 제공합니다. 주요 특징은 다음과 같습니다:
- 긍정적인 기초자산 성과에 대해 최소 158%의 레버리지 비율
- 초기 수준에서 최대 20% 하락에 대한 원금 보호
- 각 기초자산에 대해 초기 수준의 80%인 하락 임계 수준
- 증권당 추정 가치 $961.80
주요 위험 요소로는 원금 손실 가능성, 이자 지급 없음, 그리고 오직 최악의 성과를 보인 기초자산에만 노출된다는 점이 있습니다. 이 증권은 모건 스탠리의 신용 위험에 노출되며 어떠한 거래소에도 상장되지 않습니다. 만기 시 지급액은 최악의 기초자산이 100% 하락할 경우 $0(전액 손실)에서, 60% 상승할 경우 $1,948(158% 레버리지 기준)까지 변동합니다. 이번 상품은 모건 스탠리의 구조화 상품 혁신을 보여주며, 향상된 수익과 투자 위험 간의 균형을 강조합니다.
Morgan Stanley Finance a annoncé les titres Worst-of SPX and INDU Trigger PLUS arrivant à échéance le 22 juillet 2031, offrant une exposition à effet de levier sur la performance la plus faible entre l'indice S&P 500® et le Dow Jones Industrial Average℠. Les caractéristiques clés incluent :
- Facteur de levier d'au moins 158% sur la performance positive du sous-jacent
- Protection du capital contre des baisses allant jusqu'à 20% par rapport aux niveaux initiaux
- Niveau seuil à la baisse fixé à 80% du niveau initial pour chaque sous-jacent
- Valeur estimée de 961,80 $ par titre
Les risques notables comprennent la perte potentielle du capital, l'absence de paiement d'intérêts et l'exposition uniquement au sous-jacent le moins performant. Les titres sont soumis au risque de crédit de Morgan Stanley et ne seront pas cotés en bourse. Le paiement à l'échéance varie de 0 $ (perte totale) si le sous-jacent le moins performant chute de 100%, à 1 948 $ si ce même sous-jacent progresse de 60% (en supposant un levier de 158%). Cette offre illustre l'innovation continue de Morgan Stanley dans les produits structurés tout en soulignant l'équilibre entre rendements accrus et risques d'investissement.
Morgan Stanley Finance hat die Wertpapiere Worst-of SPX and INDU Trigger PLUS mit Fälligkeit am 22. Juli 2031 angekündigt, die eine gehebelte Beteiligung an der schlechteren Entwicklung des S&P 500® Index und des Dow Jones Industrial Average℠ bieten. Die wichtigsten Merkmale sind:
- Hebelfaktor von mindestens 158% bei positiver Performance des Basiswerts
- Kapitalschutz gegen Rückgänge von bis zu 20% gegenüber dem Anfangsniveau
- Abwärts-Schwellenwert bei 80% des Anfangsniveaus für jeden Basiswert
- Geschätzter Wert von 961,80 USD pro Wertpapier
Zu den wesentlichen Risiken zählen ein möglicher Kapitalverlust, keine Zinszahlungen und die Exponierung nur gegenüber dem schlechtesten Basiswert. Die Wertpapiere unterliegen dem Kreditrisiko von Morgan Stanley und werden an keiner Börse notiert. Die Auszahlung bei Fälligkeit reicht von 0 USD (Totalverlust), falls der schlechteste Basiswert 100% verliert, bis zu 1.948 USD, wenn der schlechteste Basiswert um 60% steigt (bei 158% Hebelwirkung). Das Angebot zeigt Morgan Stanleys fortwährende Innovation bei strukturierten Produkten und betont die Balance zwischen erhöhten Renditen und Investitionsrisiken.
- Significant upside potential with 158% leverage factor on positive performance of underlying indices
- Downside protection buffer of 20% helps shield investors from moderate market declines
- Dual index structure provides exposure to both S&P 500 and Dow Jones Industrial Average
- No principal protection below 80% threshold - potential for complete loss of investment
- No interest payments during the 6-year term
- Performance tied to worst-performing index, significantly increasing downside risk
- Estimated value ($961.80) is notably below the issue price ($1000), indicating significant embedded costs
- Limited secondary market liquidity due to no exchange listing
Morgan Stanley Finance ha annunciato i titoli Worst-of SPX and INDU Trigger PLUS con scadenza il 22 luglio 2031, che offrono un'esposizione con leva al peggior rendimento tra l'indice S&P 500® e il Dow Jones Industrial Average℠. Le caratteristiche principali includono:
- Fattore di leva di almeno il 158% sulle performance positive del sottostante
- Protezione del capitale contro cali fino al 20% dai livelli iniziali
- Livello soglia di ribasso al 80% del livello iniziale per ciascun sottostante
- Valore stimato di 961,80 dollari per titolo
I rischi principali comprendono la possibile perdita del capitale, l'assenza di pagamenti di interessi e l'esposizione esclusiva al sottostante con la performance peggiore. I titoli sono soggetti al rischio di credito di Morgan Stanley e non saranno quotati in alcun mercato. Il pagamento a scadenza varia da 0 dollari (perdita totale) se il peggior sottostante perde il 100%, fino a 1.948 dollari se il peggior sottostante guadagna il 60% (considerando la leva del 158%). L'offerta rappresenta l'innovazione continua di Morgan Stanley nei prodotti strutturati, evidenziando l'equilibrio tra rendimenti potenziati e rischi d'investimento.
Morgan Stanley Finance ha anunciado los valores Worst-of SPX and INDU Trigger PLUS con vencimiento el 22 de julio de 2031, que ofrecen exposición apalancada al peor desempeño entre el índice S&P 500® y el Dow Jones Industrial Average℠. Las características clave incluyen:
- Factor de apalancamiento de al menos 158% sobre el rendimiento positivo del subyacente
- Protección del capital contra caídas de hasta el 20% desde los niveles iniciales
- Nivel umbral a la baja del 80% del nivel inicial para cada subyacente
- Valor estimado de $961.80 por título
Los riesgos destacados incluyen la posible pérdida del capital, la ausencia de pagos de intereses y la exposición únicamente al subyacente con peor rendimiento. Los valores están sujetos al riesgo crediticio de Morgan Stanley y no estarán listados en ninguna bolsa. El pago al vencimiento varía desde $0 (pérdida total) si el peor subyacente cae un 100% hasta $1,948 si el peor subyacente gana un 60% (asumiendo un apalancamiento del 158%). La oferta demuestra la continua innovación de Morgan Stanley en productos estructurados, resaltando el equilibrio entre retornos mejorados y riesgos de inversión.
모건 스탠리 파이낸스는 2031년 7월 22일 만기인 Worst-of SPX and INDU Trigger PLUS 증권을 발표했습니다. 이 증권은 S&P 500® 지수와 다우 존스 산업평균지수℠ 중 성과가 더 나쁜 지수에 대해 레버리지 노출을 제공합니다. 주요 특징은 다음과 같습니다:
- 긍정적인 기초자산 성과에 대해 최소 158%의 레버리지 비율
- 초기 수준에서 최대 20% 하락에 대한 원금 보호
- 각 기초자산에 대해 초기 수준의 80%인 하락 임계 수준
- 증권당 추정 가치 $961.80
주요 위험 요소로는 원금 손실 가능성, 이자 지급 없음, 그리고 오직 최악의 성과를 보인 기초자산에만 노출된다는 점이 있습니다. 이 증권은 모건 스탠리의 신용 위험에 노출되며 어떠한 거래소에도 상장되지 않습니다. 만기 시 지급액은 최악의 기초자산이 100% 하락할 경우 $0(전액 손실)에서, 60% 상승할 경우 $1,948(158% 레버리지 기준)까지 변동합니다. 이번 상품은 모건 스탠리의 구조화 상품 혁신을 보여주며, 향상된 수익과 투자 위험 간의 균형을 강조합니다.
Morgan Stanley Finance a annoncé les titres Worst-of SPX and INDU Trigger PLUS arrivant à échéance le 22 juillet 2031, offrant une exposition à effet de levier sur la performance la plus faible entre l'indice S&P 500® et le Dow Jones Industrial Average℠. Les caractéristiques clés incluent :
- Facteur de levier d'au moins 158% sur la performance positive du sous-jacent
- Protection du capital contre des baisses allant jusqu'à 20% par rapport aux niveaux initiaux
- Niveau seuil à la baisse fixé à 80% du niveau initial pour chaque sous-jacent
- Valeur estimée de 961,80 $ par titre
Les risques notables comprennent la perte potentielle du capital, l'absence de paiement d'intérêts et l'exposition uniquement au sous-jacent le moins performant. Les titres sont soumis au risque de crédit de Morgan Stanley et ne seront pas cotés en bourse. Le paiement à l'échéance varie de 0 $ (perte totale) si le sous-jacent le moins performant chute de 100%, à 1 948 $ si ce même sous-jacent progresse de 60% (en supposant un levier de 158%). Cette offre illustre l'innovation continue de Morgan Stanley dans les produits structurés tout en soulignant l'équilibre entre rendements accrus et risques d'investissement.
Morgan Stanley Finance hat die Wertpapiere Worst-of SPX and INDU Trigger PLUS mit Fälligkeit am 22. Juli 2031 angekündigt, die eine gehebelte Beteiligung an der schlechteren Entwicklung des S&P 500® Index und des Dow Jones Industrial Average℠ bieten. Die wichtigsten Merkmale sind:
- Hebelfaktor von mindestens 158% bei positiver Performance des Basiswerts
- Kapitalschutz gegen Rückgänge von bis zu 20% gegenüber dem Anfangsniveau
- Abwärts-Schwellenwert bei 80% des Anfangsniveaus für jeden Basiswert
- Geschätzter Wert von 961,80 USD pro Wertpapier
Zu den wesentlichen Risiken zählen ein möglicher Kapitalverlust, keine Zinszahlungen und die Exponierung nur gegenüber dem schlechtesten Basiswert. Die Wertpapiere unterliegen dem Kreditrisiko von Morgan Stanley und werden an keiner Börse notiert. Die Auszahlung bei Fälligkeit reicht von 0 USD (Totalverlust), falls der schlechteste Basiswert 100% verliert, bis zu 1.948 USD, wenn der schlechteste Basiswert um 60% steigt (bei 158% Hebelwirkung). Das Angebot zeigt Morgan Stanleys fortwährende Innovation bei strukturierten Produkten und betont die Balance zwischen erhöhten Renditen und Investitionsrisiken.
Free Writing Prospectus to Preliminary Pricing Supplement No. 9,068
Registration Statement Nos. 333-275587; 333-275587-01
Dated June 25, 2025; Filed pursuant to Rule 433
Morgan Stanley
Worst-of SPX and INDU Trigger PLUS due July 22, 2031
This document provides a summary of the terms of the securities. Investors must carefully review the accompanying preliminary pricing supplement referenced below, product supplement, index supplement and prospectus, and the “Risk Considerations” on the following page, prior to making an investment decision.
|
Terms |
|
|
Issuer: |
Morgan Stanley Finance LLC |
|
Guarantor: |
Morgan Stanley |
|
Underliers: |
S&P 500® Index (SPX) and Dow Jones Industrial AverageSM (INDU) |
|
Leverage factor: |
At least 158% |
|
Downside threshold level: |
80% of the initial level for each underlier |
|
Pricing date: |
July 17, 2025 |
|
Observation date: |
July 17, 2031 |
|
Maturity date: |
July 22, 2031 |
|
CUSIP: |
61778NBU4 |
|
Estimated value: |
$961.80 per security, or within $55.00 of that estimate |
|
Preliminary pricing supplement: |
https://www.sec.gov/Archives/edgar/data/895421/000183988225034538/ms9068_424b2-18833.htm |
1All payments are subject to our credit risk
Hypothetical Payment at Maturity1
The payment at maturity will be based solely on the performance of the worst performing underlier, which could be either underlier. The payoff diagram and table below illustrate the payment at maturity for a range of hypothetical performances of the worst performing underlier over the term of the securities.
|
% Change in Closing Level of the Worst Performing Underlier |
Payment at Maturity per Security |
|
+60.00% |
$1,948.00* |
|
+40.00% |
$1,632.00* |
|
+20.00% |
$1,316.00* |
|
+10.00% |
$1,158.00* |
|
0.00% |
$1,000.00 |
|
-10.00% |
$1,000.00 |
|
-20.00% |
$1,000.00 |
|
-21.00% |
$790.00 |
|
-40.00% |
$600.00 |
|
-60.00% |
$400.00 |
|
-80.00% |
$200.00 |
|
-100.00% |
$0.00 |
*Assumes a leverage factor of 158%
The issuer has filed a registration statement (including a prospectus) with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by calling toll-free 1-800-584-6837.
Underlier(s)
For more information about the underlier(s), including historical performance information, see the accompanying preliminary pricing supplement.
Risk Considerations
The risks set forth below are discussed in more detail in the “Risk Factors” section in the accompanying preliminary pricing supplement. Please review those risk factors carefully prior to making an investment decision.
Risks Relating to an Investment in the Securities
●The securities do not guarantee the return of any principal and do not pay interest.
●The amount payable on the securities is not linked to the values of the underliers at any time other than the observation date.
●The market price of the securities may be influenced by many unpredictable factors.
●The securities are subject to our credit risk, and any actual or anticipated changes to our credit ratings or credit spreads may adversely affect the market value of the securities.
●As a finance subsidiary, MSFL has no independent operations and will have no independent assets.
●The rate we are willing to pay for securities of this type, maturity and issuance size is likely to be lower than the rate implied by our secondary market credit spreads and advantageous to us. Both the lower rate and the inclusion of costs associated with issuing, selling, structuring and hedging the securities in the original issue price reduce the economic terms of the securities, cause the estimated value of the securities to be less than the original issue price and will adversely affect secondary market prices.
●The estimated value of the securities is determined by reference to our pricing and valuation models, which may differ from those of other dealers and is not a maximum or minimum secondary market price.
●The securities will not be listed on any securities exchange and secondary trading may be limited.
●As discussed in more detail in the accompanying product supplement, investing in the securities is not equivalent to investing in the underlier(s).
●The U.S. federal income tax consequences of an investment in the securities are uncertain.
Risks Relating to the Underlier(s)
●Because your return on the securities will depend upon the performance of the underlier(s), the securities are subject to the following risk(s), as discussed in more detail in the accompanying product supplement.
oYou are exposed to the price risk of each underlier.
oBecause the securities are linked to the performance of the worst performing underlier, you are exposed to a greater risk of not receiving a positive return on the securities and/or sustaining a significant loss on your investment than if the securities were linked to just one underlier.
oAdjustments to an underlying index could adversely affect the value of the securities.
Risks Relating to Conflicts of Interest
●The calculation agent, which is a subsidiary of Morgan Stanley and an affiliate of MSFL, will make determinations with respect to the securities.
●Hedging and trading activity by our affiliates could potentially adversely affect the value of the securities.
Tax Considerations
You should review carefully the discussion in the accompanying preliminary pricing supplement under the caption “Additional Information About the Securities– United States federal income tax considerations” concerning the U.S. federal income tax consequences of an investment in the securities, and you should consult your tax adviser.
FAQ
What are the key terms of MS's Trigger PLUS securities due July 2031?
What is the maximum potential return for MS's Trigger PLUS securities?
What are the main risks of MS's Trigger PLUS securities?
How is the payment at maturity calculated for MS's Trigger PLUS?
What is the estimated value of MS's Trigger PLUS securities?
